Lifeboat Foundation

A Kickstarter campaign is launching on Tuesday for a drone you control with your mind.

The mind-controlled drone is the work EEGSmart, a Chinese company focused on the development of brain-machine interface (BMI) technology — and according to New Atlas writer Loz Blain, who got a chance to test the device, “It’s not perfect, but it does give a glimpse of a mind-controlled future.”

I know some people don’t like it but the Lunar Gateway is getting more traction.

The International Space Station partners have endorsed plans to continue the development of the Gateway, an outpost around the Moon that will act as a base to support both robots and astronauts exploring the lunar surface.

The Multilateral Coordination Board, which oversees the management of the Space Station, stressed its common hope for the Gateway to open up a cost-effective and sustainable path to the Moon and beyond.

The fundamental idea of OpenAI LP is that investors and employees can get a capped return if we succeed at our mission, which allows us to raise investment capital and attract employees with startup-like equity. But any returns beyond that amount—and if we are successful, we expect to generate orders of magnitude more value than we’d owe to people who invest in or work at OpenAI LP—are owned by the original OpenAI Nonprofit entity.

We’ve created OpenAI LP, a new “capped-profit” company that allows us to rapidly increase our investments in compute and talent while including checks and balances to actualize our mission.

A common oral bacteria has been found to release a molecule that accelerates the growth of colorectal cancers. The impressive new research could lead to new cancer treatments as well as offer a valuable biomarker to help doctors identify potentially aggressive cancers.

Scripps Research scientists have discovered a compound that potently and selectively kills the stem-like cells that make glioblastoma brain cancers so deadly.

In a study published this week in The Proceedings of the National Academy of Sciences, the Scripps Research scientists found that the new compound, which they dubbed RIPGBM, kills glioblastoma stem-like cells cultured from patients’ tumors with more than 40 times the potency of the standard GBM drug temozolomide. They found too that RIPGBM is highly selective, sparing other types of brain cells, and that it powerfully suppresses the growth of GBM tumors in a mouse model of the disease.

“Our discovery of this compound and the cellular pathways it affects offers a promising new strategy for treating glioblastoma,” says principal investigator Luke Lairson, PhD, an assistant professor of chemistry at Scripps Research.

Continue reading “Promising compound selectively kills brain cancer stem cells” »

How to keep your assets intact if you’re revived through cryonics.

Traditionally, welding has been limited to materials that share similar properties, so it’s tough to make even aluminum and steel join forces. But now, scientists from Heriot-Watt University are claiming a breakthrough method that can weld together materials as different as glass and metal, thanks to ultrafast laser pulses.

Five years ago, French aeronautical engineer Edwin Van Ruymbeke successfully crowdfunded his Bionic Bird – it’s a remote-control model that flies by flapping its wings, just like a real bird. Now he’s back, with the insect-inspired MetaFly.

The research contradicts a major assumption in physics.